Zoledronic Acid With Intermittent Hormonal Therapy in Patients With Prostate Cancer
This study has been completed.
Sponsor:
Stanford University
Collaborator:
Novartis
Information provided by:
Stanford University
ClinicalTrials.gov Identifier:
NCT00226954
First received: September 13, 2005
Last updated: July 27, 2009
Last verified: July 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | February 2009 |
| Primary Completion Date: | November 2007 (Final data collection date for primary outcome measure) |